BIOMAT Database Logo BIOMAT Database Logo

Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. 2002

R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Infectious Diseases Unit, Haemek Medical Center, Afula; and Technion, Institute of Technology, Haifa, Israel. raz_r@clalit.org.il

This study evaluated whether trimethoprim-sulfamethoxazole (TMP-SMX) is effective for treatment of uncomplicated urinary tract infections (UTIs) due to TMP-SMX-resistant (TMP-SMX-R) pathogens. Healthy nonpregnant premenopausal women with symptomatic lower UTI were assessed for the presence of pyuria and bacteriuria; if either was present, a urine sample was cultured and TMP-SMX was prescribed. Clinical and microbiologic cure was assessed at days 5-9 and 28-42 after cessation of therapy. For 71%, of patients, cultures grew TMP-SMX-susceptible (TMP-SMX-S) microorganisms, and for 29%, cultures grew TMP-SMX-R organisms. Escherichia coli remained the predominant bacteria in both groups of cultures. At visit 2, microbiological cure had been achieved in 86% of the patients in the TMP-SMX-S group and 42% of those in the TMP-SMX-R group. Similar differences were found at visit 3 by clinical evaluation. Treatment with TMP-SMX of uncomplicated UTI caused by TMP-SMX-R microorganisms results in microbiologic and clinical failure. In high-resistance areas, TMP-SMX should not be the empiric drug of choice for uncomplicated UTI.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003556 Cystitis Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain. Cystitides
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000892 Anti-Infective Agents, Urinary Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. Antiseptics, Urinary,Antiinfective Agents, Urinary,Urinary Anti-Infective Agents,Urinary Antiinfective Agents,Agents, Urinary Anti-Infective,Agents, Urinary Antiinfective,Anti Infective Agents, Urinary,Urinary Anti Infective Agents,Urinary Antiseptics
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D014930 Women Human females as cultural, psychological, sociological, political, and economic entities. Girls,Woman,Women's Groups,Girl,Women Groups,Women's Group
D015662 Trimethoprim, Sulfamethoxazole Drug Combination A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. Trimethoprim-Sulfamethoxazole Combination,Abactrim,Bactifor,Bactrim,Biseptol,Biseptol-480,Centran,Centrin,Co-Trimoxazole,Cotrimoxazole,Drylin,Eslectin,Eusaprim,Insozalin,Kepinol,Kepinol Forte,Lescot,Metomide,Oriprim,Septra,Septrin,Sulfamethoxazole-Trimethoprim Combination,Sulprim,Sumetrolim,TMP SMX,TMP-SMX,Trimedin,Trimethoprim-Sulfamethoxazole,Trimethoprimsulfa,Trimezole,Trimosulfa,Biseptol 480,Biseptol480,Co Trimoxazole,Sulfamethoxazole Trimethoprim Combination,Trimethoprim Sulfamethoxazole,Trimethoprim Sulfamethoxazole Combination

Related Publications

R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Empiric use of trimethoprim-sulfamethoxazole(TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographic area with a high prevalence of TMP-SMX-resistant uropathogens.
October 2002, The Journal of urology,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
January 2015, Folia medica Cracoviensia,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
[Parenteral chemotherapy in urinary tract infections with trimethoprim/sulfamethoxazole (TMP/SMZ)].
June 1976, Die Medizinische Welt,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI.
June 2002, International journal of antimicrobial agents,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).
April 1978, European journal of pediatrics,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxis.
November 2020, Clinical transplantation,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Empiric treatment of uncomplicated urinary tract infections.
November 1998, The Annals of pharmacotherapy,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections.
November 1989, Urology,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Long-term treatment of sulfa-resistant urinary tract infections with a sulfamethoxazole-trimethoprim combination.
January 1978, Journal of clinical pharmacology,
R Raz, and B Chazan, and Y Kennes, and R Colodner, and E Rottensterich, and M Dan, and I Lavi, and W Stamm, and
Trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
December 1975, The Medical letter on drugs and therapeutics,
Copied contents to your clipboard!